BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29780735)

  • 21. The effect of interleukin-17F on vasculogenic mimicry in oral tongue squamous cell carcinoma.
    Almahmoudi R; Salem A; Hadler-Olsen E; Svineng G; Salo T; Al-Samadi A
    Cancer Sci; 2021 Jun; 112(6):2223-2232. PubMed ID: 33743555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-27b functions as a new inhibitor of ovarian cancer-mediated vasculogenic mimicry through suppression of
    Liu W; Lv C; Zhang B; Zhou Q; Cao Z
    RNA; 2017 Jul; 23(7):1019-1027. PubMed ID: 28396577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lupeol and Paclitaxel cooperate in hindering hypoxia induced vasculogenic mimicry via suppression of HIF-1α-EphA2-Laminin-5γ2 network in human oral cancer.
    Saha D; Mitra D; Alam N; Sen S; Mustafi SM; Majumder PK; Majumder B; Murmu N
    J Cell Commun Signal; 2023 Sep; 17(3):591-608. PubMed ID: 36063341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ZEB2 promotes vasculogenic mimicry by TGF-β1 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma.
    Yang Z; Sun B; Li Y; Zhao X; Zhao X; Gu Q; An J; Dong X; Liu F; Wang Y
    Exp Mol Pathol; 2015 Jun; 98(3):352-9. PubMed ID: 25818166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with β-catenin expression.
    Umbreit C; Flanjak J; Weiss C; Erben P; Aderhold C; Faber A; Stern-Straeter J; Hoermann K; Schultz JD
    Anticancer Res; 2014 Dec; 34(12):7061-9. PubMed ID: 25503133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin.
    Delgado-Bellido D; Serrano-Saenz S; Fernández-Cortés M; Oliver FJ
    Mol Cancer; 2017 Mar; 16(1):65. PubMed ID: 28320399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD276 Promotes Vasculogenic Mimicry Formation in Hepatocellular Carcinoma via the PI3K/AKT/MMPs Pathway.
    Cheng R; Wang B; Cai XR; Chen ZS; Du Q; Zhou LY; Ye JM; Chen YL
    Onco Targets Ther; 2020; 13():11485-11498. PubMed ID: 33204103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-cadherin participated in invasion and metastasis of human esophageal squamous cell carcinoma via taking part in the formation of vasculogenic mimicry.
    Wang F; Li XK; Xu HY; Shan ZZ; Wang T; Yang ZC; He W; Wang LX; Fan QX
    Med Oncol; 2015 Feb; 32(2):480. PubMed ID: 25575439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epithelial-mesenchymal transition regulated by EphA2 contributes to vasculogenic mimicry formation of head and neck squamous cell carcinoma.
    Wang W; Lin P; Sun B; Zhang S; Cai W; Han C; Li L; Lu H; Zhao X
    Biomed Res Int; 2014; 2014():803914. PubMed ID: 24864260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of LGR5 in oral squamous cell carcinoma and its correlation to vasculogenic mimicry.
    Wu Z; Song W; Cheng Z; Yang D; Yu L
    Int J Clin Exp Pathol; 2017; 10(11):11267-11275. PubMed ID: 31966480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelial Phosphatase VE-PTP Participates in Vasculogenic Mimicry by Preventing Autophagic Degradation of VE-Cadherin.
    Delgado-Bellido D; Bueno-Galera C; López-Jiménez L; Garcia-Diaz A; Oliver FJ
    Front Oncol; 2020; 10():18. PubMed ID: 32117706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry.
    Sun T; Zhao N; Zhao XL; Gu Q; Zhang SW; Che N; Wang XH; Du J; Liu YX; Sun BC
    Hepatology; 2010 Feb; 51(2):545-56. PubMed ID: 19957372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epithelial-Mesenchymal Transition Predicts Survival in Oral Squamous Cell Carcinoma.
    Wangmo C; Charoen N; Jantharapattana K; Dechaphunkul A; Thongsuksai P
    Pathol Oncol Res; 2020 Jul; 26(3):1511-1518. PubMed ID: 31471883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined overexpression of cadherin 6, cadherin 11 and cluster of differentiation 44 is associated with lymph node metastasis and poor prognosis in oral squamous cell carcinoma.
    Ma C; Zhao JZ; Lin RT; Zhou L; Chen YN; Yu LJ; Shi TY; Wang M; Liu MM; Liu YR; Zhang T
    Oncol Lett; 2018 Jun; 15(6):9498-9506. PubMed ID: 29805672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor budding of cervical squamous cell carcinoma: epithelial-mesenchymal transition-like cancer stem cells?
    Zheng S; Luo J; Xie S; Lu S; Liu Q; Xiao H; Luo W; Huang Y; Liu K
    PeerJ; 2022; 10():e13745. PubMed ID: 35860042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potentiated action on the progression of OSMF by hypoxia mediated signaling pathway by the epithelial mesenchymal transition and angiogenic apparatus.
    Gupta S; Shetty DC; Gulati N; Juneja S; Jain A
    J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of e-cadherin and vimentin expression for different grades of oral epithelial dysplasia and oral squamous cell carcinoma - An immunohistochemical study.
    Puneeta N; Santosh T; Mishra I; Gaikwad P; Sahu A
    J Oral Maxillofac Pathol; 2022; 26(2):285-286. PubMed ID: 35968190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of epithelial-mesenchymal transition markers at the invasive front of oral squamous cell carcinoma.
    Costa LC; Leite CF; Cardoso SV; Loyola AM; Faria PR; Souza PE; Horta MC
    J Appl Oral Sci; 2015; 23(2):169-78. PubMed ID: 26018309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasculogenic mimicry and expression of slug and vimentin correlate with metastasis and prognosis in non-small cell lung cancer.
    Song H; Ci H; Xu J; Xu Z; Zhang Y; Wang Y; Wu S; Tao Y
    Int J Clin Exp Pathol; 2018; 11(5):2749-2758. PubMed ID: 31938392
    [No Abstract]   [Full Text] [Related]  

  • 40. MTDH in macrophages promotes the vasculogenic mimicry via VEGFA-165/Flt-1 signaling pathway in head and neck squamous cell carcinoma.
    Liu X; Lv Z; Zhou S; Kan S; Liu X; Jing P; Xu W
    Int Immunopharmacol; 2021 Jul; 96():107776. PubMed ID: 34162144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.